Allife Medical Science and Technology

Main focus: Next generation cellular therapies

Company stage: Clinical

Diseases: Beta-thalassemia, hematological - and solid tumors

Genome editing tool: CRISPR-Cas9

Funding stage: Private

Location: Beijing, China


Allife Medical Science and Technology is a company focused on developing next generation cellular therapies for the treatment of genetic diseases and cancers. The company uses CRISPR to genetically modify its cellular products, and currently runs multiple clinical trials.


HashtagAllife Medical Science and Technology Co., Ltd

Search CRISPR Medicine